Drug "Ebrantil" instructions for usedefines as an antihypertensive agent with central and peripheral effects. The main component of the drug - urapidil - affects the vasomotor center, reduces peripheral total vascular resistance, resulting in reduced diastolic and systolic blood pressure. At the same time, the drug "Ebrantil" practically does not change the frequency of heart contractions and cardiac output.
In the form of a solution intended forparenteral use, the drug is prescribed to patients with hypertensive crisis, arterial hypertension (refractory, severe). In order to lower blood pressure before and after surgical interventions, the injection solution Ebrantil is also used. Tablets are a dosage form that is not characteristic of this drug, but Ebrantil capsules are available, which have been shown to be used in case of arterial hypertension.
Form of issue and composition
As already noted, the production of the drugcarried out in the form of capsules (in bottles of 50, 100 units) and solution for injection (in ampoules of 5, 10 ml). One capsule contains 30 or 60 mg of urapidil, and 1 ml of the solution contains 5 mg.
Method of use of the Ebrantil
Adverse Events
It is extremely rare in the process of therapy develop.negative effects. In isolated situations, the occurrence of adverse events such as thrombocytopenia, cardiac arrhythmias, angina pectoris, severe decrease in blood pressure, orthostatic hypotension was noted. There is also a risk of nausea, diarrhea, dry mouth, dizziness, high fatigue, sleep disturbances, headaches, causeless anxiety. Allergic reactions may develop: erythema, urticaria, anaphylactic shock.
Ebrantil is not prescribed to people who haveintolerance included in the ingredients, as well as patients with galactosemia, lactase deficiency. Injection solution is not used to treat patients with aortic stenosis. In pediatric practice, the drug is not used.